Paul L. Prather
Affiliations: | University of Arkansas for Medical Sciences, United States |
Area:
Pharmacology, Neuroscience BiologyGoogle:
"Paul Prather"Mean distance: 21373.2
Children
Sign in to add traineeJennifer Shoemaker | grad student | 2007 | UAMS |
Kathryn A. Seely | grad student | 2009 | UAMS |
Maheswari Rajasekaran | grad student | 2011 | UAMS |
Lisa K. Brents | grad student | 2013 | UAMS |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Janganati V, Salazar P, Parks BJ, et al. (2023) Deuterated buprenorphine retains pharmacodynamic properties of buprenorphine and resists metabolism to the active metabolite norbuprenorphine in rats. Frontiers in Pharmacology. 14: 1123261 |
Cabanlong CV, Russell LN, Fantegrossi WE, et al. (2022) Metabolites of Synthetic Cannabinoid 5F-MDMB-PINACA Retain Affinity, Act as High Efficacy Agonists and Exhibit Atypical Pharmacodynamic Properties at CB1 Receptors. Toxicological Sciences : An Official Journal of the Society of Toxicology |
Penthala NR, Shoeib A, Dachavaram SS, et al. (2020) 7-Azaindolequinuclidinones (7-AIQD): A novel class of cannabinoid 1 (CB1) and cannabinoid 2 (CB2) receptor ligands. Bioorganic & Medicinal Chemistry Letters. 30: 127501 |
Pinson A, Yarbrough AL, Bush JM, et al. (2020) Metabolism, CB1 cannabinoid receptor binding and in vivo activity of synthetic cannabinoid 5F-AKB48: Implications for toxicity. Pharmacology, Biochemistry, and Behavior. 172949 |
Jones S, Yarbrough AL, Fantegrossi WE, et al. (2020) Identifying cytochrome P450s involved in oxidative metabolism of synthetic cannabinoid N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (STS-135). Pharmacology Research & Perspectives. 8: e00561 |
Ford BM, Cabanlong CV, Tai S, et al. (2019) Reduced tolerance and asymmetrical cross-tolerance to effects of indole quinuclidinone analogue PNR-4-20, a G protein biased CB1R agonist in mice: comparisons with Δ9-THC and JWH-018. The Journal of Pharmacology and Experimental Therapeutics |
Jones S, Yarbrough AL, Shoeib A, et al. (2019) Enzymatic Analysis of Glucuronidation of Synthetic Cannabinoid 1-Naphthyl 1-(4-fluorobenzyl)-1H-indole-3-carboxylate (FDU-PB-22). Xenobiotica; the Fate of Foreign Compounds in Biological Systems. 1-25 |
Yarbrough AL, Pinson A, Prather PL, et al. (2019) Oxidative Metabolism and Comparative Analysis of Synthetic Cannabinoid N-(1-adamantyl)-1-(5-fluoropentyl)indazole-3-carboxamide (5F-AKB-48) and the Unfluorinated Analog AKB-48 The Faseb Journal. 33 |
Yarbrough A, Fujiwara R, Fantegrossi W, et al. (2019) Oxidative metabolism of synthetic cannabinoid STS-135 by recombinant P450S and human liver microsomes Drug Metabolism and Pharmacokinetics. 34: S28 |
Hutchison RD, Ford BM, Franks LN, et al. (2018) Atypical Pharmacodynamic Properties and Metabolic Profile of the Abused Synthetic Cannabinoid AB-PINACA: Potential Contribution to Pronounced Adverse Effects Relative to Δ-THC. Frontiers in Pharmacology. 9: 1084 |